lOMoARcPSD|285 053 80
lOMoARcPSD|285 053 80
ATI Pharmacology Proctor 2026
1.) A nurse is assessing a client who is receiving intravenous therapy. The nurse should identify which
of the following findings as a manifestation of fluid volume excess?
a. Decreased bowel sounds
b. Distended neck veins
c. Bilateral muscle weakness
d. Thread pulse
2.) A nurse is caring for a client who has hyponatremia and is receiving an infusion of a prescribed
hypertonic solution. Which of the following findings should indicate to the nurse that the
treatment is effective?
a. Absent Chvostek9s sign
b. Improved cognition
c. Decreased vomiting
d. Cardiac arrhythmias absent
3.) A nurse is teaching a client who has a new prescription for a nitroglycerin transdermal patch.
Which of the following instructions should the nurse include?
a. <Discontinue the patch if you experience a headache.=
b. <Apply a new patch if you have chest pain.=
c. <Cover the patch with dry gauze when taking a shower.=
d. <Remove the patch prior to going to bed.=
4.) A nurse is reviewing he laboratory results of a client who has a prescription for sodium
polystyrene sulfonate (Kayexalate) every 6 hr. which of the following should the nurse report to
the provider?
a. Creatinine 0.72 mg/dL
b. Sodium 138 mEq/L
c. Magnesium 2 mEq/L
d. Potassium 5.2 mEq/L - Hyperkalemia (serum potassium level greater than 5.0 mEq/L)
increases the client risk for fatal cardiac dysrhythmias. Kayexalate is used to decrease the
serum potassium level, so the PN should monitor the client's serum potassium level
5.) A nurse is caring for a client who has tuberculosis and is taking isoniazid and rifampin. Which of
the following outcomes indicates that the client is adhering to the medication regimen?
a. The client has a negative sputum culture
b. The client tests negative for HIV
c. The client has a positive purified protein derivative test
d. The client9s liver function test results are within the expected reference range
6.) A client is caring for a client who develops an anaphylactic reaction to IV administration. After
assessing the client9s respiratory status and stopping the medication infusion. Which of the
following actions should the nurse take next?
a. Replace the infusion with 0.9% sodium chloride
b. Give diphenhydramine IM
c. Elevate the client9s legs and feet
, lOMoARcPSD|285 053 80
d. Administer mepinephrine mIM m
m
m
m
m
m
7.) A mnurse mis mcaring mfor ma mclient mwho mis mtaking msertraline mand mreports ma mdesire mto mbegin
mtaking msupplements. mWhich mof mthe mfollowing msupplements mshould mthe mnurse madvise mthe
mclient mto mavoid? ma. mSt. mJohn9s mWort m m
b. Ginger mroot m
c. Black mcohosh m
d. Coenzyme mQ10 m
8.) A mnurse mis mcaring mfor ma mclient mwho mhas mheart mfailure mand ma mnew mprescription mfor mlisinopril.
mFor mwhich mof mthe mfollowing madverse meffects mshould mthe mnurse mmonitor mwhen
madministering mlisinopril? ma. mBradycardia m
b. Hypokalemia m
c. Tinnitus m
d. mHypotension m
9.) mA mnurse mis massessing ma mclient mwho mis mreceiving mheparin mIV mcontinuous mIV. mThe mclient mhas man
mPPT mof m90 mseconds. mThey mshould mmonitor mthe mclient mfor mwhich mof mthe mfollowing mchanges min
mtheir mvital msigns? ma. mDecreased mtemperature m
b. Increased mpulse mrate m
c. Decreased mrespiratory mrate m
d. mIncreased mblood mpressure m m
10.) mA mnurse mis mpreparing mto madminister mmedication mto ma mclient mand mdiscovers ma mmedication
merror. mThe mnurse mshould mrecognize mthat mwhich mof mthe mfollowing mstaff mmembers mis
mresponsible mfor mcompleting man mincident mreport? m
a. mThe mquality mimprovement mcommittee m
b. mThe mnurse mwho midentifies mthe merror m m
c. The mnurse mwho mcaused mthe merror m
d. The mcharge mnurse m
11.) A mnurse mis mplanning mcare mfor ma mclient mwho mis mreceiving mmorphine mvia mcontinuous mepidural
minfusion. m
The mnurse mshould mmonitor mthe mclient mfor mwhich mof mthe mfollowing? m
a. Pruritus m3 mSign mof mallergic mreaction mto mmorphine m
b. Cough m
c. Tachypnea m
d. Gastric mbleeding m
12.) A mnurse mis mpreparing mto madminister mdigoxin morally mto ma mclient. mIdentify mthe msequence mof
msteps mthe mnurse mshould mtake. m(Move mthe msteps minto mthe mbox mon mthe mright,
mplacing mthem min mthe morder mof mperformance. mUse mall mthe msteps.) m
, lOMoARcPSD|285 053 80
a. mObtain m m m m m m m m m m m m mthe m m m m m m m m m m m m mclient9s m m m m m m m m m m m m mapical m m m m m m m m m
m m m m mheart m m m m m m m m m m m m m mrate mb. m m m m m m mRemove m m m m m mthe m m m m m mmedication m m m
m m mfrom m m m m m mthe m m m m m mdispensing m m m m m msystem mc. mOpen m m m m m m m m m m m m m m m m m m m m
m m m m mthe m m m m m m m m m m m m m m m m m m m m m m m m m mmedication m m m m m m m m m m m m m m m m m m m m m m m m m
mpackage m
d. mCompare mthe mclient9s mwristband mto mthe mmedication madministration
mrecord
m
e. mDocument madministration mof mthe
mmedication m
m
m
m
m
13.) mA mnurse mis mreviewing mthe mmedical mrecord mof man madult mclient mwho mhas ma mfever mand ma
mprescription mfor macetaminophen. mWhich mof mthe mfollowing mfindings mshould mthe mnurse
midentify mas ma mcontraindication m
for mreceiving mthis mmedication? m
a. mAlcohol muse mdisorder m
b. mChronic mkidney mdisease m
c. Hepatitis mB mvaccine mwithin mthe mlast mweek m
d. Diabetes mmellitus m
14.) mA mhome mhealth mnurse mis mvisiting ma mclient mwho mhas mheart mfailure mand ma mprescription mfor
mfurosemide. mThe mnurse midentifies mthat mthe mclient mhas mgained m2.5 mkg m(5 mlb.) msince mthe mlast
mvisit m2 mdays mago. mWhich mof mthe mfollowing mactions mshould mthe mnurse mtake mfirst? m
a. Encourage mthe mclient mto mdangle mthe mlegs mwhile msitting min ma mchair m
b. Teach mthe mclient mabout mfoods mlow min msodium m
c. mDetermine mmedication madherence mby mthe mclient m m
d. mNotify mthe mprovider mof mthe mclient9s mweight mgain m
15.) A mnurse mis mpreparing mto madminister mthe minitial mdose mof mpenicillin mG mIM mto ma mclient. mThe
mnurse mshould mmonitor mfor mwhich mof mthe mfollowing mas man mindication mof man mallergic mreaction
mfollowing mthe minjection? ma. mUrticaria m m
b. Bradycardia m
c. Pallor m
d. Dyspepsia m
16.) A mnurse mis mteaching ma mclient mwho mhas mangina ma mnew mprescription mfor msublingual
mnitroglycerin mtablets. mWhich mof mthe mfollowing minstructions mshould mthe mnurse minclude min mthe
mteaching? m
a. <Discard many mtablets myou mdo mnot muse mevery m6 mmonths.= m
b. <Take mone mtablet meach mmorning m30 mminutes mprior mto meating.= m
, lOMoARcPSD|285 053 80
c. m<Keep mthe mtablets mat mroom mtemperature min mtheir moriginal mglass mbotle.= m
d. m<Place mthe mtablet mbetween myour mcheek mand mgum mto mdissolve.= m
17.) mA mnurse mis mproviding mteaching mto ma mclient mwho mhas ma mnew mprescription mfor
mtheophylline, ma msustained-released mcapsule. mWhich mof mthe mfollowing mstatements mby
mthe mclient mindicates man munderstanding mof mthe mteaching? m
a. m<I mcan mtake mmy mmedication min mthe mmorning mwith mmy mcoffee.= m
b. <I mmay msprinkle mthe mmedication min mapplesauce.= m
c. <I mshould mlimit mmy mfluid mintake mwhile mon mthis mmedication.= m
d. <I mwill mneed mto mhave mblood mlevels mdrawn.= m m
18.)A mnurse mis mmixing mregular minsulin mand mNPH minsulin min mthe msame msyringe mprior mto
madministering mit mto mclient mwho mhas mdiabetes mmellitus mfollowing mactions mshould mthe mnurse
mtake mfirst? m
a. Withdraw mthe mregular minsulin mfrom mthe mviral m
b. Withdraw mthe mNPH minsulin mform mthe mvial m
c. Inject mair minto mthe mNPH mvial m m m
d. Inject mair minto mthe mregular minsulin mvial m m
m
m
m
m
19.)A mnurse mis mpreparing mto madminister msubcutaneous mheparin mto ma mclient. mWhich mof mthe
mfollowing mshould mthe mnurse mtake? m
a. Massage mthe msite mafter madministering mthe mmedication m
b. Use ma m21-gauge mneedle mfor mthe minjection m
c. Aspirate mbefore minjecting mthe mmedication m
d. mInsert mthe mneedle mat mleast m5 mcm m(2 min) mfrom mthe
mumbilicus m
20.)A mnurse mis mcaring mfor ma mclient mwho mhas ma mprescription mfor mamoxicillin. mWhich mof mthe
mfollowing mfindings mindicates mthe mclient mis mexperiencing man mallergic mreaction? m
a. mNausea m
b. mCardiac mdysrhythmia m
c. Laryngeal medema m
d. Insomnia m
21.)A mnurse mis mteaching ma mnewly mlicensed mnurse mabout mmedication mreconciliation. mThe mnurse
mshould minstruct mthe mnewly mlicensed mnurse mto mperform mmedication mreconciliation mfor
mwhich mof mthe mfollowing? m
a. A mclient mwho mhas ma mreferral mfor msocial mservices m
b. A mclient mwho mis mtransdermal mto mradiology m
c. mA mclient mwho mis mtransferal mto ma mstep-down munit m
d. mA mclient mwho mhas ma mconsultation mfor mphysical mtherapy m
22.)A mnurse mis mreviewing mthe mlaboratory mvalues mof ma mclient mwho mis mtaking matorvastatin. mWhich
mof mthe mfollowing mlaboratory mvalues mindicates mthe mtreatment mhas mbeen meffective? m
a. BUN m15 mmg/dL m
b. Blood mglucose m90 mmg/dL m
c. Urine mspecific mgravity m1.020 m
lOMoARcPSD|285 053 80
ATI Pharmacology Proctor 2026
1.) A nurse is assessing a client who is receiving intravenous therapy. The nurse should identify which
of the following findings as a manifestation of fluid volume excess?
a. Decreased bowel sounds
b. Distended neck veins
c. Bilateral muscle weakness
d. Thread pulse
2.) A nurse is caring for a client who has hyponatremia and is receiving an infusion of a prescribed
hypertonic solution. Which of the following findings should indicate to the nurse that the
treatment is effective?
a. Absent Chvostek9s sign
b. Improved cognition
c. Decreased vomiting
d. Cardiac arrhythmias absent
3.) A nurse is teaching a client who has a new prescription for a nitroglycerin transdermal patch.
Which of the following instructions should the nurse include?
a. <Discontinue the patch if you experience a headache.=
b. <Apply a new patch if you have chest pain.=
c. <Cover the patch with dry gauze when taking a shower.=
d. <Remove the patch prior to going to bed.=
4.) A nurse is reviewing he laboratory results of a client who has a prescription for sodium
polystyrene sulfonate (Kayexalate) every 6 hr. which of the following should the nurse report to
the provider?
a. Creatinine 0.72 mg/dL
b. Sodium 138 mEq/L
c. Magnesium 2 mEq/L
d. Potassium 5.2 mEq/L - Hyperkalemia (serum potassium level greater than 5.0 mEq/L)
increases the client risk for fatal cardiac dysrhythmias. Kayexalate is used to decrease the
serum potassium level, so the PN should monitor the client's serum potassium level
5.) A nurse is caring for a client who has tuberculosis and is taking isoniazid and rifampin. Which of
the following outcomes indicates that the client is adhering to the medication regimen?
a. The client has a negative sputum culture
b. The client tests negative for HIV
c. The client has a positive purified protein derivative test
d. The client9s liver function test results are within the expected reference range
6.) A client is caring for a client who develops an anaphylactic reaction to IV administration. After
assessing the client9s respiratory status and stopping the medication infusion. Which of the
following actions should the nurse take next?
a. Replace the infusion with 0.9% sodium chloride
b. Give diphenhydramine IM
c. Elevate the client9s legs and feet
, lOMoARcPSD|285 053 80
d. Administer mepinephrine mIM m
m
m
m
m
m
7.) A mnurse mis mcaring mfor ma mclient mwho mis mtaking msertraline mand mreports ma mdesire mto mbegin
mtaking msupplements. mWhich mof mthe mfollowing msupplements mshould mthe mnurse madvise mthe
mclient mto mavoid? ma. mSt. mJohn9s mWort m m
b. Ginger mroot m
c. Black mcohosh m
d. Coenzyme mQ10 m
8.) A mnurse mis mcaring mfor ma mclient mwho mhas mheart mfailure mand ma mnew mprescription mfor mlisinopril.
mFor mwhich mof mthe mfollowing madverse meffects mshould mthe mnurse mmonitor mwhen
madministering mlisinopril? ma. mBradycardia m
b. Hypokalemia m
c. Tinnitus m
d. mHypotension m
9.) mA mnurse mis massessing ma mclient mwho mis mreceiving mheparin mIV mcontinuous mIV. mThe mclient mhas man
mPPT mof m90 mseconds. mThey mshould mmonitor mthe mclient mfor mwhich mof mthe mfollowing mchanges min
mtheir mvital msigns? ma. mDecreased mtemperature m
b. Increased mpulse mrate m
c. Decreased mrespiratory mrate m
d. mIncreased mblood mpressure m m
10.) mA mnurse mis mpreparing mto madminister mmedication mto ma mclient mand mdiscovers ma mmedication
merror. mThe mnurse mshould mrecognize mthat mwhich mof mthe mfollowing mstaff mmembers mis
mresponsible mfor mcompleting man mincident mreport? m
a. mThe mquality mimprovement mcommittee m
b. mThe mnurse mwho midentifies mthe merror m m
c. The mnurse mwho mcaused mthe merror m
d. The mcharge mnurse m
11.) A mnurse mis mplanning mcare mfor ma mclient mwho mis mreceiving mmorphine mvia mcontinuous mepidural
minfusion. m
The mnurse mshould mmonitor mthe mclient mfor mwhich mof mthe mfollowing? m
a. Pruritus m3 mSign mof mallergic mreaction mto mmorphine m
b. Cough m
c. Tachypnea m
d. Gastric mbleeding m
12.) A mnurse mis mpreparing mto madminister mdigoxin morally mto ma mclient. mIdentify mthe msequence mof
msteps mthe mnurse mshould mtake. m(Move mthe msteps minto mthe mbox mon mthe mright,
mplacing mthem min mthe morder mof mperformance. mUse mall mthe msteps.) m
, lOMoARcPSD|285 053 80
a. mObtain m m m m m m m m m m m m mthe m m m m m m m m m m m m mclient9s m m m m m m m m m m m m mapical m m m m m m m m m
m m m m mheart m m m m m m m m m m m m m mrate mb. m m m m m m mRemove m m m m m mthe m m m m m mmedication m m m
m m mfrom m m m m m mthe m m m m m mdispensing m m m m m msystem mc. mOpen m m m m m m m m m m m m m m m m m m m m
m m m m mthe m m m m m m m m m m m m m m m m m m m m m m m m m mmedication m m m m m m m m m m m m m m m m m m m m m m m m m
mpackage m
d. mCompare mthe mclient9s mwristband mto mthe mmedication madministration
mrecord
m
e. mDocument madministration mof mthe
mmedication m
m
m
m
m
13.) mA mnurse mis mreviewing mthe mmedical mrecord mof man madult mclient mwho mhas ma mfever mand ma
mprescription mfor macetaminophen. mWhich mof mthe mfollowing mfindings mshould mthe mnurse
midentify mas ma mcontraindication m
for mreceiving mthis mmedication? m
a. mAlcohol muse mdisorder m
b. mChronic mkidney mdisease m
c. Hepatitis mB mvaccine mwithin mthe mlast mweek m
d. Diabetes mmellitus m
14.) mA mhome mhealth mnurse mis mvisiting ma mclient mwho mhas mheart mfailure mand ma mprescription mfor
mfurosemide. mThe mnurse midentifies mthat mthe mclient mhas mgained m2.5 mkg m(5 mlb.) msince mthe mlast
mvisit m2 mdays mago. mWhich mof mthe mfollowing mactions mshould mthe mnurse mtake mfirst? m
a. Encourage mthe mclient mto mdangle mthe mlegs mwhile msitting min ma mchair m
b. Teach mthe mclient mabout mfoods mlow min msodium m
c. mDetermine mmedication madherence mby mthe mclient m m
d. mNotify mthe mprovider mof mthe mclient9s mweight mgain m
15.) A mnurse mis mpreparing mto madminister mthe minitial mdose mof mpenicillin mG mIM mto ma mclient. mThe
mnurse mshould mmonitor mfor mwhich mof mthe mfollowing mas man mindication mof man mallergic mreaction
mfollowing mthe minjection? ma. mUrticaria m m
b. Bradycardia m
c. Pallor m
d. Dyspepsia m
16.) A mnurse mis mteaching ma mclient mwho mhas mangina ma mnew mprescription mfor msublingual
mnitroglycerin mtablets. mWhich mof mthe mfollowing minstructions mshould mthe mnurse minclude min mthe
mteaching? m
a. <Discard many mtablets myou mdo mnot muse mevery m6 mmonths.= m
b. <Take mone mtablet meach mmorning m30 mminutes mprior mto meating.= m
, lOMoARcPSD|285 053 80
c. m<Keep mthe mtablets mat mroom mtemperature min mtheir moriginal mglass mbotle.= m
d. m<Place mthe mtablet mbetween myour mcheek mand mgum mto mdissolve.= m
17.) mA mnurse mis mproviding mteaching mto ma mclient mwho mhas ma mnew mprescription mfor
mtheophylline, ma msustained-released mcapsule. mWhich mof mthe mfollowing mstatements mby
mthe mclient mindicates man munderstanding mof mthe mteaching? m
a. m<I mcan mtake mmy mmedication min mthe mmorning mwith mmy mcoffee.= m
b. <I mmay msprinkle mthe mmedication min mapplesauce.= m
c. <I mshould mlimit mmy mfluid mintake mwhile mon mthis mmedication.= m
d. <I mwill mneed mto mhave mblood mlevels mdrawn.= m m
18.)A mnurse mis mmixing mregular minsulin mand mNPH minsulin min mthe msame msyringe mprior mto
madministering mit mto mclient mwho mhas mdiabetes mmellitus mfollowing mactions mshould mthe mnurse
mtake mfirst? m
a. Withdraw mthe mregular minsulin mfrom mthe mviral m
b. Withdraw mthe mNPH minsulin mform mthe mvial m
c. Inject mair minto mthe mNPH mvial m m m
d. Inject mair minto mthe mregular minsulin mvial m m
m
m
m
m
19.)A mnurse mis mpreparing mto madminister msubcutaneous mheparin mto ma mclient. mWhich mof mthe
mfollowing mshould mthe mnurse mtake? m
a. Massage mthe msite mafter madministering mthe mmedication m
b. Use ma m21-gauge mneedle mfor mthe minjection m
c. Aspirate mbefore minjecting mthe mmedication m
d. mInsert mthe mneedle mat mleast m5 mcm m(2 min) mfrom mthe
mumbilicus m
20.)A mnurse mis mcaring mfor ma mclient mwho mhas ma mprescription mfor mamoxicillin. mWhich mof mthe
mfollowing mfindings mindicates mthe mclient mis mexperiencing man mallergic mreaction? m
a. mNausea m
b. mCardiac mdysrhythmia m
c. Laryngeal medema m
d. Insomnia m
21.)A mnurse mis mteaching ma mnewly mlicensed mnurse mabout mmedication mreconciliation. mThe mnurse
mshould minstruct mthe mnewly mlicensed mnurse mto mperform mmedication mreconciliation mfor
mwhich mof mthe mfollowing? m
a. A mclient mwho mhas ma mreferral mfor msocial mservices m
b. A mclient mwho mis mtransdermal mto mradiology m
c. mA mclient mwho mis mtransferal mto ma mstep-down munit m
d. mA mclient mwho mhas ma mconsultation mfor mphysical mtherapy m
22.)A mnurse mis mreviewing mthe mlaboratory mvalues mof ma mclient mwho mis mtaking matorvastatin. mWhich
mof mthe mfollowing mlaboratory mvalues mindicates mthe mtreatment mhas mbeen meffective? m
a. BUN m15 mmg/dL m
b. Blood mglucose m90 mmg/dL m
c. Urine mspecific mgravity m1.020 m
